DeepHealth has launched the Breast Suite, a modular AI-powered platform designed to support breast cancer detection, risk stratification, and diagnostic workflow efficiency.
The 111th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2025) opened with a powerful message of unity, scientific progress, and the expanding impact of precision medicine.
A major study presented at the RSNA reveals that invasive breast cancer is more common in younger women than previously assumed, underscoring the need to revisit current screening and risk-assessment strategies.
Gnosis for Her has unveiled a mobile breast care unit featuring an FDA-cleared 3D breast CT system that provides high-resolution imaging without compression, improving comfort and accessibility for women’s breast diagnostics.
Lunit’s AI solutions for mammography and digital breast tomosynthesis are now available to over 1,500 French public hospitals through a four-year framework agreement with UniHA and partner Fujifilm.
A new AI-powered software analyzes mammograms to predict a woman's personalized five-year risk of developing breast cancer, earning the FDA’s Breakthrough Device designation.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
